Log in
onclick="gourl('https://www.adsalecprj.com/en/auth/register.html')" v-if="!userInfo.id"> Register
Contact
{{userInfo.company_name_english||userInfo.truename_english}}
{{userInfo.phone||userInfo.email}}

Home Page

Member Center

Data Settings

Log out

 
Injection

K 2025 Live: ENGEL acquires physical foaming pioneer Trexel

Oct 9, 2025

ENGEL is strengthening its technological leadership in foaming by acquiring its long-standing partner, Trexel Inc. Trexel will continue to operate independently, maintaining its own sales, service, and R&D teams.

 

Headquartered in Massachusetts, USA, Trexel is a pioneer in physical foaming and is renowned for developing and commercializing MuCell technology, a microcellular foaming process used in injection molding. The company will also remain dedicated to the footwear segment without any changes.

 

“We are convinced that this technology (physical foaming) holds tremendous potential. With ENGEL in the background, Trexel can operate independently while benefiting from the global strength of our group,” said Stefan Engleder, CEO of the ENGEL Group.

 

Going forward, Trexel will operate as Trexel GmbH, with its headquarters in Austria. The existing sites in the USA, Germany, and China will remain unchanged, ensuring continued sales and service for the global customer base.


ENGEL PC_2.jpg

(Left) Stefan Engleder, CEO of the ENGEL Group, shared company updates during the press conference at K 2025.

Foaming: A Strategic field for the future

 

ENGEL has collaborated with Trexel for many years. Together with initiatives in chemical foaming, the acquisition further solidifies ENGEL’s leadership in physical foaming.

 

“Through this acquisition, we are accelerating the further integration of MuCell into the injection molding process. We also now have the ability to scale more easily — because we are convinced that foaming is a growth market,” added Engleder.

 

This technology is also a key building block for enhancing sustainability, as foamed products are lighter, require less raw material, and contribute to a reduced carbon footprint.


Turnover expected to drop 7%


In financial year 2024/25, ENGEL achieved a turnover of 1.5 billion euros. For the current year, turnover is expected to decline by around seven per cent to 1.4 billion euros, reflecting the broader economic slowdown in many regions.


“Our industry faces major tasks - from digitalization and skills shortage to the circular economy,” said Stefan Engleder. “We focus on well-thought-out innovations with real customer benefits - and on partnerships at eye level.”

 

“Every crisis is an opportunity to position ourselves more clearly – by truly listening to our customers and delivering solutions that provide real benefits,” he concluded.

Acquisition
ENGEL
Comments
Corporate News
The new site in Serbia is part of a targeted evolution of ENGEL's European manufacturing architecture.
Sep 21, 2026
Injection
ENGEL will show its autonomous injection molding cell with an upgrade of ENGEL Virtual Assistant (EVA), demonstrating how ENGEL is turning artificial intelligence (AI) into measurable production performance.
Sep 11, 2026
Injection
At Fakuma 2026, ENGEL’s victory electric 1565/220 will mold a high-precision LSR seal for inverter component live on the stand – flash-free, straight out of the machine, no rework needed.
Sep 10, 2026
Injection
Billion will remain an independent company and will recommend ENGEL as its preferred machine supplier.
Sep 2, 2026
Injection
At Fakuma 2026, a two-platen injection molding machine from WINTEC will run live production of coat hangers, showing off its strength in high-volume manufacturing.
Aug 27, 2026
Corporate News
ARBURG will acquire Stork Plastics Machinery B.V. (Stork IMM), based in Hengelo, the Netherlands, from Stibbe Participaties B.V.
Jul 31, 2026
Share Your Choice
Facebook
X
Email